 cytomegaloviru infect allogen bone marrow transplant cytomegaloviru cmv infect recipi allogen bone marrow transplant cmv-seroposit patient cmv-seroneg patient sourc infect reactiv latent endogen viru blood product cmv-seroposit blood donor use marrow cmv-seroposit donor cmv-seroneg recipi common sever clinic syndrom cmv infect allogen transplant recipi interstiti pneumonia patient risk factor cmv pneumonia old age total-bodi irradi sever graft-vs.-host diseas rapid diagnosi cmv pneumonia immunochem stain bronchoalveolar lavag fluid centrifug cell cultur cmv monoclon antibodi treatment cmv pneumonia problemat therapi combin intraven immun globulin ivig ganciclovir surviv rate previou trial antivir therapi cmv-seroneg patient cmv infect pneumonia use cmv-seroneg blood product ivig ivig addit benefit infecti complic graft-vs.-host diseas patient cmv-seroneg blood product cmv-seroposit patient effect prophylaxi cmv reactiv pneumonia clinic trial prophylact ganciclovir way